Anaplastic thyroid cancer
Clinical trials for Anaplastic thyroid cancer explained in plain language.
Never miss a new study
Get alerted when new Anaplastic thyroid cancer trials appear
Sign up with your email to follow new studies for Anaplastic thyroid cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Keytruda takes on deadly thyroid cancer in tiny trial
Disease control OngoingThis Phase 2 trial tests the immunotherapy drug pembrolizumab (Keytruda) in 12 people with advanced anaplastic thyroid cancer, a rare and fast-growing cancer with no standard cure. Participants receive the drug every three weeks to see if tumors shrink or stop growing. The study …
Matched conditions: ANAPLASTIC THYROID CANCER
Phase 2 • Sponsor: Saad A Khan • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for advanced thyroid cancer: personalized drug cocktails tested
Disease control OngoingThis early-phase trial tests whether giving advanced thyroid cancer patients a personalized mix of already-approved drugs, chosen based on their tumor's genetic profile, is feasible and safe. Ten patients with no other treatment options will receive individualized drug combinatio…
Matched conditions: ANAPLASTIC THYROID CANCER
Phase 1 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Two-Drug combo takes aim at deadly thyroid cancer
Disease control OngoingThis early-phase trial tests the safety and tolerability of combining two drugs—trametinib and paclitaxel—in people with anaplastic thyroid cancer, a rare and fast-growing cancer that is difficult to treat. The study aims to see how this drug pair affects tumor growth and shrinka…
Matched conditions: ANAPLASTIC THYROID CANCER
Early phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Immunotherapy added to standard drugs may fight aggressive thyroid cancer
Disease control OngoingThis study tests whether adding the immunotherapy drug cemiplimab to the usual combination of dabrafenib and trametinib can shrink tumors in people with a rare and aggressive form of thyroid cancer called anaplastic thyroid cancer. Participants have a specific genetic mutation (B…
Matched conditions: ANAPLASTIC THYROID CANCER
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New pill shows promise for Hard-to-Treat cancers in early trial
Disease control OngoingThis early-phase study tests a new oral drug called E7386 in about 60 adults with advanced solid tumors (like desmoid tumors) that have not responded to other treatments. The main goals are to find the safest dose and check for side effects. Researchers will also watch for any tu…
Matched conditions: ANAPLASTIC THYROID CANCER
Phase 1 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New drug combo shows promise against deadly thyroid cancer
Disease control OngoingThis phase 2 study is testing a combination of two drugs, nivolumab and lenvatinib, in 51 people with anaplastic thyroid cancer that cannot be removed by surgery. The goal is to see if the treatment is safe and can shrink tumors. Anaplastic thyroid cancer is rare and fast-growing…
Matched conditions: ANAPLASTIC THYROID CANCER
Phase 2 • Sponsor: National Cancer Center Hospital East • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Urine test may spot hidden thyroid cancer, avoid unnecessary surgery
Diagnosis OngoingThis study looks at whether proteins found in urine can help doctors diagnose follicular thyroid cancer before surgery. Currently, this type of thyroid cancer can only be confirmed after removing the thyroid. Researchers will collect urine samples from 50 patients with thyroid no…
Matched conditions: ANAPLASTIC THYROID CANCER
Sponsor: National Taiwan University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC